Formation of a Human β-Cell Population within Pancreatic Islets Is Set Early in Life
Open accessThe DOI matches its Crossref record; 43 of the 50 references it cites were found in a registry or an index.
Abstract
CONTEXT: Insulin resistance can be compensated by increased functional pancreatic β-cell mass; otherwise, diabetes ensues. Such compensation depends not only on environmental and genetic factors but also on the baseline β-cell mass from which the expansion originates. OBJECTIVE: Little is known about assembly of a baseline β-cell mass in humans. Here, we examined formation of β-cell populations relative to other pancreatic islet cell types and associated neurons throughout the normal human lifespan. DESIGN AND METHODS: Human pancreatic sections derived from normal cadavers aged 24 wk premature to 72 yr were examined by immunofluorescence. Insulin, glucagon, and somatostatin were used as markers for β-, α-, and δ-cells, respectively. Cytokeratin-19 marked ductal cells, Ki67 cell proliferation, and Tuj1 (neuronal class III β-tubulin) marked neurons. RESULTS: Most β-cell neogenesis was observed preterm with a burst of β-cell proliferation peaking within the first 2 yr of life. Thereafter, little indication of β-cell growth was observed. Postnatal proliferation of α- and δ-cells was rarely seen, but a wave of ductal cell proliferation was found mostly associated with exocrine cell expansion. The β-cell to α-cell ratio doubled neonatally, reflecting increased growth of β-cells, but during childhood, there was a 7-fold change in the β-cell to δ-cell ratio, reflecting an additional loss of δ-cells. A close association of neurons to pancreatic islets was noted developmentally and retained throughout adulthood. Negligible neuronal association to exocrine pancreas was observed. CONCLUSION: Human baseline β-cell population and appropriate association with other islet cell types is established before 5 yr of age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both of these concepts of pathogenesis of type 1 diabetes have been debated.50,51”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent data suggest that although most patients with longstanding type 1 diabetes have few β cells, if any, there is evidence for β-cell regeneration in infants and very young children (but not in adolescents or adults).51,52”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“β-Cell mass increases during the first decade of life due to proliferation during the first 5 years ( 53 , 54 ), stabilizing during adolescence with considerable variation (three- to fivefold) unrelated to age or BMI.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [53]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Through these and other studies, analyses of pancreata from individuals with recent-onset type 1 diabetes suggest that around 70% of islets display complete insulin absence;51,52”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Self-citationBrissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797
Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683
Intrauterine Growth Retardation Leads to the Development of Type 2 Diabetes in the Rat
Simmons, R. A., Templeton, L. J., & Gertz, S. J. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2279 · Cited by 638
Sorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Brissova, M., Shostak, A., Shiota, M., Wiebe, P. O., Poffenberger, G., Kantz, J., Chen, Z., Carr, C., Jerome, W. G., Chen, J., et al. (2006) · Diabetes · doi:10.2337/db06-0690 · Cited by 442
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
Butler, A. E., Cao-Minh, L., Galasso, R., Rizza, R. A., Corradin, A., Cobelli, C., & Butler, P. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1809-6 · Cited by 435
Studies on the pancreas of the guinea pig
Bensley, R. R. (1911) · American Journal of Anatomy · doi:10.1002/aja.1000120304 · Cited by 426
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Self-citationGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Beta Cell Dysfunction and Insulin Resistance
Cerf, M. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00037 · Cited by 964
“Postnatally, human beta cell neogenesis was observed at a negligible rate of≤0.5% in normal human pancreata with several rare instances of beta cell neogenesis observed at 1, 15, and 39 years (Gregg et al., 2012).”
BackgroundInfluentialPancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes
Aguayo-Mazzucato, C., Andle, J., Lee, T. B., Midha, A., Talemal, L., Chipashvili, V., Hollister-Lock, J., van Deursen, J., Weir, G., & Bonner-Weir, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.006 · Cited by 469
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
“the first 5 years (53,54), stabilizing dur-”
Self-citationNair, G. G., Liu, J. S., Russ, H. A., Tran, S., Saxton, M. S., Chen, R., Juang, C., Li, M.-L., Nguyen, V. Q., Giacometti, S., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0271-4 · Cited by 472
Self-citationBalboa, D., Barsby, T., Lithovius, V., Saarimäki-Vire, J., Omar-Hmeadi, M., Dyachok, O., Montaser, H., Lund, P.-E., Yang, M., Ibrahim, H., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01219-z · Cited by 433
Wang, P., Alvarez-Perez, J.-C., Felsenfeld, D. P., Liu, H., Sivendran, S., Bender, A., Kumar, A., Sanchez, R., Scott, D. K., Garcia-Ocaña, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3820 · Cited by 404
Zhou, Q., & Melton, D. A. (2018) · Nature · doi:10.1038/s41586-018-0088-0 · Cited by 385
Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
Campbell-Thompson, M., Fu, A., Kaddis, J. S., Wasserfall, C., Schatz, D. A., Pugliese, A., & Atkinson, M. A. (2016) · Diabetes · doi:10.2337/db15-0779 · Cited by 356
“Reports indicate marked variability in β-cell area or mass in normal adults with adult levels reached by 5 years (17; 18; 46; 47).”
BackgroundSelf-citationStructural similarities and differences between the human and the mouse pancreas
Dolenšek, J., Rupnik, M. S., & Stožer, A. (2015) · Islets · doi:10.1080/19382014.2015.1024405 · Cited by 348
“Studies on human islets from the prenatal period to late adulthood provide evidence that human islets probably attain an adult architecture by 2 y after birth.(86,96) This is accompanied by an increase in beta cell area and mass, as well as beta to alpha cell ratio, predominantly due to a burst of beta cell proliferat…”
BackgroundInfluentialIslet β cell mass in diabetes and how it relates to function, birth, and death
Weir, G. C., & Bonner‐Weir, S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12031 · Cited by 296
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Saisho, Y. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.109 · Cited by 263
Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes
Aguayo-Mazzucato, C., & Bonner-Weir, S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.007 · Cited by 237
SerpinB1 Promotes Pancreatic β Cell Proliferation
El Ouaamari, A., Dirice, E., Gedeon, N., Hu, J., Zhou, J.-Y., Shirakawa, J., Hou, L., Goodman, J., Karampelias, C., Qiang, G., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.001 · Cited by 234
Natural history of β-cell adaptation and failure in type 2 diabetes
Alejandro, E. U., Gregg, B., Blandino-Rosano, M., Cras-Méneur, C., & Bernal-Mizrachi, E. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.002 · Cited by 232
Self-citationA 3D map of the islet routes throughout the healthy human pancreas
Ionescu-Tirgoviste, C., Gagniuc, P. A., Gubceac, E., Mardare, L., Popescu, I., Dima, S., & Militaru, M. (2015) · Scientific Reports · doi:10.1038/srep14634 · Cited by 233
Age-Dependent Pancreatic Gene Regulation Reveals Mechanisms Governing Human β Cell Function
Arda, H. E., Li, L., Tsai, J., Torre, E. A., Rosli, Y., Peiris, H., Spitale, R. C., Dai, C., Gu, X., Qu, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.002 · Cited by 222
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“β-cell mass increases during the first decade of life due to proliferation during the first five years (53, 54), stabilizing during adolescence with considerable variation (3-5 fold) unrelated to age or BMI.”
BackgroundSelf-citationInhibition of DYRK1A Stimulates Human β-Cell Proliferation
Dirice, E., Walpita, D., Vetere, A., Meier, B. C., Kahraman, S., Hu, J., Dančík, V., Burns, S. M., Gilbert, T. J., Olson, D. E., et al. (2016) · Diabetes · doi:10.2337/db15-1127 · Cited by 209
“In contrast, adult human b-cell replication has been reported to be virtually absent, suggesting that the capacity to replicate plateaus at ;10 years of age (14,15).”
BackgroundDiabetes mellitus—advances and challenges in human β-cell proliferation
Wang, P., Fiaschi-Taesch, N. M., Vasavada, R. C., Scott, D. K., García-Ocaña, A., & Stewart, A. F. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.9 · Cited by 205
Insulin Resistance Alters Islet Morphology in Nondiabetic Humans
Mezza, T., Muscogiuri, G., Sorice, G. P., Clemente, G., Hu, J., Pontecorvi, A., Holst, J. J., Giaccari, A., & Kulkarni, R. N. (2014) · Diabetes · doi:10.2337/db13-1013 · Cited by 206
“89390, reacting equally with intact GLP-1 (7-36) amide and its primary N-terminally truncated metabolite GLP-1 (9-36) amide.”
BackgroundThe Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations
Lee, P. G., & Halter, J. B. (2017) · Diabetes Care · doi:10.2337/dc16-1732 · Cited by 203
“Other studies using C(14) or Ki67 have found that human adult b-cell turnover is very low (16,17,22,23).”
BackgroundMethodβ Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance
Aguayo-Mazzucato, C., van Haaren, M., Mruk, M., Lee, T. B., Crawford, C., Hollister-Lock, J., Sullivan, B. A., Johnson, J. W., Ebrahimi, A., Dreyfuss, J. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.015 · Cited by 198
Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes
Weir, G. C., Gaglia, J., & Bonner-Weir, S. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30022-x · Cited by 194
Exosome-Derived MicroRNAs of Human Milk and Their Effects on Infant Health and Development
Melnik, B. C., Stremmel, W., Weiskirchen, R., John, S. M., & Schmitz, G. (2021) · Biomolecules · doi:10.3390/biom11060851 · Cited by 184
Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas
Wang, Y. J., Golson, M. L., Schug, J., Traum, D., Liu, C., Vivek, K., Dorrell, C., Naji, A., Powers, A. C., Chang, K.-M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.007 · Cited by 160
“…al., 2015; Brissova et al., 2005; Cabrera et al., 2006); (2) the decline of human pancreatic endocrine cell replication with age (Cnop et al., 2010; Gregg et al., 2012; Meier et al., 2008; Perl et al., 2010; Reers et al., 2009); and (3) the mitogenic effect of harmine on pancreatic endocrine cells…”
BackgroundResultInfluentialWang, P., Karakose, E., Liu, H., Swartz, E., Ackeifi, C., Zlatanic, V., Wilson, J., González, B. J., Bender, A., Takane, K. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.005 · Cited by 162
“…confirmed in multi- ple laboratories, replicates the proliferation ‘‘rate’’ in human beta cells in the first year of life, the only stage of human development at which appreciable beta cell proliferation occurs (Gregg et al., 2012; Kassem et al., 2000;Meier et al., 2008;Wang et al., 2015b).”
InfluentialThe role of aging upon β cell turnover
Kushner, J. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64095 · Cited by 159
“Butler and colleagues and Rhodes and colleagues have similarly reported very low rates of β cell proliferation in human adult subjects, as detected by Ki67 content (27–29).”
Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes
Balboa, D., Saarimäki-Vire, J., Borshagovski, D., Survila, M., Lindholm, P., Galli, E., Eurola, S., Ustinov, J., Grym, H., Huopio, H., et al. (2018) · eLife · doi:10.7554/elife.38519 · Cited by 155
Signals in the pancreatic islet microenvironment influence β‐cell proliferation
Aamodt, K. I., & Powers, A. C. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13031 · Cited by 181
Neural regulation of pancreatic islet cell mass and function
Thorens, B. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12346 · Cited by 140
“In humans the early postnatal period has also been shown to involve a high β-cell proliferation rate that is important to define adult β-cell mass [46,47].”
BackgroundAtkinson, M. A., von Herrath, M., Powers, A. C., & Clare-Salzler, M. (2015) · Diabetes Care · doi:10.2337/dc15-0144 · Cited by 145
Self-citationDai, C., Hang, Y., Shostak, A., Poffenberger, G., Hart, N., Prasad, N., Phillips, N., Levy, S. E., Greiner, D. L., Shultz, L. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91761 · Cited by 144
Pseudotemporal Ordering of Single Cells Reveals Metabolic Control of Postnatal β Cell Proliferation
Zeng, C., Mulas, F., Sui, Y., Guan, T., Miller, N., Tan, Y., Liu, F., Jin, W., Carrano, A. C., Huising, M. O., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.014 · Cited by 144
“During this period, beta-cell mass expands substantially in both mice and humans owing to a neonatal burst in beta-cell proliferation (Finegood et al., 1995; Gregg et al., 2012).”
BackgroundAge-Related Impairment of Pancreatic Beta-Cell Function: Pathophysiological and Cellular Mechanisms
De Tata, V. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00138 · Cited by 142
Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
Hart, N. J., & Powers, A. C. (2018) · Diabetologia · doi:10.1007/s00125-018-4772-2 · Cited by 167
Beta cells in type 1 diabetes: mass and function; sleeping or dead?
Oram, R. A., Sims, E. K., & Evans‐Molina, C. (2019) · Diabetologia · doi:10.1007/s00125-019-4822-4 · Cited by 149
“During early human development, beta cells are thought to arise either via neogenesis from progenitor cells and ductal precursor cells or through replication of existing beta cells [48].”
Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
Moin, A. S. M., & Butler, A. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1194-6 · Cited by 147
Lee, J., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094843 · Cited by 172
Pancreatic β-Cell Proliferation in Obesity
Linnemann, A. K., Baan, M., & Davis, D. B. (2014) · Advances in Nutrition · doi:10.3945/an.113.005488 · Cited by 132
“and establishment of adult b-cell mass likely occurs within the first few years of life (17,18).”
BackgroundAtkinson, M. A., & Mirmira, R. G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.018 · Cited by 145
Self-citationPugliese, A., Yang, M., Kusmarteva, I., Heiple, T., Vendrame, F., Wasserfall, C., Rowe, P., Moraski, J. M., Ball, S., Jebson, L., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12097 · Cited by 132
Self-citationRole of Cellular Senescence in Type II Diabetes
Narasimhan, A., Flores, R. R., Robbins, P. D., & Niedernhofer, L. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab136 · Cited by 133
Murakami, T., Inagaki, N., & Kondoh, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869414 · Cited by 152
Preterm birth and risk of type 1 and type 2 diabetes: a national cohort study
Crump, C., Sundquist, J., & Sundquist, K. (2020) · Diabetologia · doi:10.1007/s00125-019-05044-z · Cited by 125
A conserved bacterial protein induces pancreatic beta cell expansion during zebrafish development
Hill, J. H., Franzosa, E. A., Huttenhower, C., & Guillemin, K. J. (2016) · eLife · doi:10.7554/elife.20145 · Cited by 132
“In humans, b cells undergo a period of postnatal expansion, before becoming quiescent around age two (Gregg et al., 2012).”
BackgroundNair, G., & Hebrok, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.03.004 · Cited by 114
New insights into the architecture of the islet of Langerhans: a focused cross-species assessment
Drigo, R. A. E., Ali, Y., Díez, J., Srinivasan, D. K., Berggren, P., & Boehm, B. O. (2015) · Diabetologia · doi:10.1007/s00125-015-3699-0 · Cited by 129
Jacovetti, C., Matkovich, S. J., Rodriguez-Trejo, A., Guay, C., & Regazzi, R. (2015) · Nature Communications · doi:10.1038/ncomms9084 · Cited by 111
Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review
Inaishi, J., & Saisho, Y. (2020) · Nutrients · doi:10.3390/nu12123846 · Cited by 107
“Since beta-cell replication is more frequently observed in the first five years of life [29,30], childhood obesity or birthweight might affect beta-cell mass.”
BackgroundRosario, W., Singh, I., Wautlet, A., Patterson, C., Flak, J., Becker, T. C., Ali, A., Tamarina, N., Philipson, L. H., Enquist, L. W., et al. (2016) · Diabetes · doi:10.2337/db15-0629 · Cited by 106
“As the majority of neuronal projections in the pancreas are targeted to pancreatic islets (13,14), it has been assumed that this approach predominantly highlights efferent brain linkage to the endocrine pancreas compared with the exocrine tissue (22,23).”
BackgroundSelf-citationAlarcón, C., Boland, B. B., Uchizono, Y., Moore, P. C., Peterson, B. F., Rajan, S., Rhodes, O. S., Noske, A. B., Haataja, L., Arvan, P. R., et al. (2015) · Diabetes · doi:10.2337/db15-0792 · Cited by 102
“sections for immunofluorescence confocal microscopy as described (17; 18).”
MethodSelf-citationFunctional changes in beta cells during ageing and senescence
Aguayo‐Mazzucato, C. (2020) · Diabetologia · doi:10.1007/s00125-020-05185-6 · Cited by 113
Pancreas development in humans
Pan, F. C., & Brissova, M. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000047 · Cited by 87
Direct Autocrine Action of Insulin on β-Cells: Does It Make Physiological Sense?
Rhodes, C., White, M., Leahy, J., & Kahn, S. (2013) · Diabetes · doi:10.2337/db13-0246 · Cited by 100
Self-citationIslet biology, the CDKN2A/B locus and type 2 diabetes risk
Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3967-7 · Cited by 104
“Human autopsy studies report an age-dependent reduction in beta cell proliferation [102, 106, 107].”
Adult Consequences of Extremely Preterm Birth
Nuyt, A. M., Lavoie, J., Mohamed, I., Paquette, K., & Luu, T. M. (2017) · Clinics in Perinatology · doi:10.1016/j.clp.2017.01.010 · Cited by 113
“Pancreatic b cells are formed predominantly during the third trimester and then proliferate until about 2 years.(84) A maladaptive intrauterine or extrauterine environment (eg, preterm birth) could disrupt development of b-cell mass with subsequent low insulin secretion.”
BackgroundRichardson, S. J., & Morgan, N. G. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.07.006 · Cited by 112
Impact of fetal and neonatal environment on beta cell function and development of diabetes
Nielsen, J. H., Haase, T. N., Jaksch, C., Nalla, A., Søstrup, B., Nalla, A. A., Larsen, L., Rasmussen, M., Dalgaard, L. T., Gaarn, L. W., et al. (2014) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12504 · Cited by 103
the United States Neonatal Diabetes Working Group, Thurber, B. W., Carmody, D., Tadie, E. C., Pastore, A. N., Dickens, J. T., Wroblewski, K. E., Naylor, R. N., Philipson, L. H., & Greeley, S. A. W. (2015) · Diabetologia · doi:10.1007/s00125-015-3593-9 · Cited by 85
“It remains to be seen whether patients who initiated SU at an early age and currently require lower doses will eventually have failure of beta cell function and require higher doses or other medications as they age, although early reports suggest that doses remain stable [20, 21].”
BackgroundBeta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect
Almaça, J., Caicedo, A., & Landsman, L. (2020) · Diabetologia · doi:10.1007/s00125-020-05186-5 · Cited by 92
Leete, P., Mallone, R., Richardson, S. J., Sosenko, J. M., REDONDO, M. J., & Evans‐Molina, C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1083-4 · Cited by 92
The Human Islet: Mini-Organ With Mega-Impact
Walker, J. T., Saunders, D. C., Briššová, M., & Powers, A. C. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab010 · Cited by 97
Bogdani, M., Blackman, S. M., Ridaura, C., Bellocq, J. P., Powers, A. C., & Aguilar‐Bryan, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-17404-z · Cited by 80
The pancreatic β-cell in ageing: Implications in age-related diabetes
Tudurí, E., Soriano, S., Almagro, L., Montanya, E., Alonso‐Magdalena, P., Nadal, Á., & Quesada, I. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101674 · Cited by 104
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement
Bartlett, S. T., Markmann, J. F., Johnson, P., Korsgren, O., Hering, B. J., Scharp, D., Kay, T. W. H., Bromberg, J., Odorico, J. S., Weir, G. C., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001055 · Cited by 75
“Much of the evidence that β cells do not replicate comes from studies done on pancreases obtained at autopsy or from cadaver donors.(335,342) The most commonly used tool for assessing β-cell replication is Ki67, but it is well known in studies of cancer pathology that the numbers of mitotic”
MethodDYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes
Kumar, K., Suebsuwong, C., Wang, P., García-Ocaña, A., Stewart, A. F., & DeVita, R. J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02050 · Cited by 81
The Streetlight Effect in Type 1 Diabetes
Battaglia, M., & Atkinson, M. A. (2015) · Diabetes · doi:10.2337/db14-1208 · Cited by 75
Self-citationNervous glucose sensing regulates postnatal β cell proliferation and glucose homeostasis
Tarussio, D., Metref, S., Seyer, P., Mounien, L., Vallois, D., Magnan, C., Foretz, M., & Thorens, B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69154 · Cited by 71
“These observations are similar to those made in humans, which showed an intense phase of β cell expansion in infancy thought to be critical for the establishment of a basal β cell mass, possibly influencing the susceptibility to develop type 2 diabetes (51, 52).”
Perinatal Origins of Adult Disease and Opportunities for Health Promotion: A Narrative Review
Nobile, S., Morgia, C. D. S., & Vento, G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020157 · Cited by 86
The Genetic Architecture of Type 1 Diabetes
Jerram, S. T., & Leslie, R. D. (2017) · Genes · doi:10.3390/genes8080209 · Cited by 94
“A recent study found that GRS could distinguish clinically defined T1D and Type 2 diabetes from the Wellcome Trust Case Control Consortium, and that the T1D GRS correctly classified young adults (diagnosed at 20–40 years of age, an age with maximum diagnostic difficulty in clinical practice) who progressed to severe i…”
Methodβ cells persist in T1D pancreata without evidence of ongoing β-cell turnover or neogenesis
Lam, C. J., Jacobson, D. R., Rankin, M. M., Cox, A. R., & Kushner, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3806 · Cited by 68
Islet Neogenesis: A Possible Pathway for Beta-Cell Replenishment
Bonner‐Weir, S., Guo, L., Li, W., Ouziel-Yahalom, L., Weir, G. C., & Sharma, A. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.407 · Cited by 79
Saisho, Y. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.132 · Cited by 71
Advances in β cell replacement and regeneration strategies for treating diabetes
Benthuysen, J. R., Carrano, A. C., & Sander, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87439 · Cited by 78
Targeting pancreatic β cells for diabetes treatment
Jain, C., Ansarullah, M., Bilekova, S., & Lickert, H. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00618-5 · Cited by 71
Chen, H., Kleinberger, J. W., Takane, K. K., Salim, F., Fiaschi-Taesch, N., Pappas, K., Parsons, R., Jiang, J., Zhang, Y., Liu, H., et al. (2015) · Diabetes · doi:10.2337/db15-0083 · Cited by 59
β-cell neogenesis: A rising star to rescue diabetes mellitus
Niu, F., Liu, W., Ren, Y., Tian, Y., Shi, W., Li, M., Li, Y., Xiong, Y., & Lü, Q. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.10.008 · Cited by 77
“The self-replicating of b -cells has gained widespread attention as the most direct way to restore pancreatic b -cell volume and mass. Conventional wisdom has long held that b -cell proliferation primarily occurs during the late embryonic and neonatal stages [110,111].”
BackgroundSelf-citationPancreatic islet cell development and regeneration
Romer, A. I., & Sussel, L. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000174 · Cited by 62
Chien, H., Chiang, T., Peng, S.-J., Chung, M., Chou, Y.-H., Lee, C., Jeng, Y., Tien, Y., & Tang, S. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00116.2019 · Cited by 63
Levasseur, E. M., Yamada, K., Piñeros, A. R., Wu, W., Syed, F., Orr, K. S., Anderson-Baucum, E., Mastracci, T. L., Maier, B., Mosley, A. L., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aax0715 · Cited by 58
“First, although cells were originally considered to be postmitotic cells in the adult mammal, it is now recognized that they exhibit a slow rate of replication that decreases with age (11, 12, 17, 43).”
BackgroundShin, C. H., & Choi, D. (2019) · Cells · doi:10.3390/cells8020178 · Cited by 62
“Given the slow rate of β-cell regeneration in adult humans [145,146], Xu and colleagues used a transgenic zebrafish model of T1D and performed a chemical–genetic screen to identify additional small molecule enhancers of β-cell regeneration [48].”
BackgroundSerotonin Regulates Adult β-Cell Mass by Stimulating Perinatal β-Cell Proliferation
Moon, J. H., Kim, Y. G., Kim, K., Osonoi, S., Wang, S., Saunders, D. C., Wang, J., Yang, K., Kim, H., Lee, J., et al. (2020) · Diabetes · doi:10.2337/db19-0546 · Cited by 54
Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges
Wang, P., Karaköse, E., Choleva, L., Kumar, K., DeVita, R. J., García-Ocaña, A., & Stewart, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671946 · Cited by 60
Age‐associated changes of islet endocrine cells and the effects of body mass index in Japanese
Mizukami, H., Takahashi, K., Inaba, W., Osonoi, S., Kamata, K., Tsuboi, K., & Yagihashi, S. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12118 · Cited by 54
Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas
Inaishi, J., Saisho, Y., Sato, S., Kou, K., Murakami, R., Watanabe, Y., Kitago, M., Kitagawa, Y., Yamada, T., & Itoh, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1374 · Cited by 54
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations
Ardestani, A. D., & Maedler, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00167 · Cited by 60
The supply chain of human pancreatic β cell lines
Scharfmann, R., Staels, W., & Albagli, O. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129484 · Cited by 60
(Re)generating Human Beta Cells: Status, Pitfalls, and Perspectives
Baeyens, L., Lemper, M., Staels, W., Groef, S. D., Leu, N. D., Heremans, Y., German, M. S., & Heimberg, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2016 · Cited by 62
Yagihashi, S., Inaba, W., & Mizukami, H. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12424 · Cited by 51
Making β Cells from Adult Cells Within the Pancreas
Lysy, P. A., Weir, G. C., & Bonner‐Weir, S. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0400-1 · Cited by 60
Neiman, D., Gillis, D., Piyanzin, S., Cohen, D., Fridlich, O., Moss, J., Zick, A., Oron, T., Sundberg, F., Forsander, G., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136579 · Cited by 51
“10 the quiescent nature of β-cells during postnatal life (28), β-cell-derived cfDNA was extremely rare in plasma from healthy subjects.”
BackgroundSelf-citationRegulation of Pdx1 by oxidative stress and Nrf2 in pancreatic beta-cells
Baumel-Alterzon, S., & Scott, D. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011187 · Cited by 61
“This peak of proliferation, which is temporary, substantially declines with age (50).”
BackgroundBiomarkers of β-Cell Stress and Death in Type 1 Diabetes
Mirmira, R. G., Sims, E. K., Syed, F., & Evans‐Molina, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0783-x · Cited by 52
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells
Balhuizen, A., Massa, S., Mathijs, I., Turatsinze, J., Vos, J. D., Demine, S., Xavier, C., Villate, O., Millard, I., Egrise, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15417-2 · Cited by 49
The Role of MicroRNAs in Diabetes-Related Oxidative Stress
Qadir, M. M. F., Klein, D., Álvarez-Cubela, S., Domínguez‐Bendala, J., & Pastori, R. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215423 · Cited by 52
“Since beta cells have notoriously low proliferating rates in adults, replenishing beta cell mass remains one of the greatest challenges of modern biology [8,9].”
BackgroundSullivan, B. A., Hollister-Lock, J., Bonner-Weir, S., & Weir, G. C. (2015) · Diabetes · doi:10.2337/db14-1675 · Cited by 47
“However, evidence of active replication was found in many of the pancreases of children younger than the age of 10 years (2,4).”
BackgroundMethod
Metadata
- Authors
- Gregg, B. E., Moore, P. C., Demozay, D., Hall, B. A., Li, M., Husain, A., Wright, A. J., Atkinson, M. A., & Rhodes, C. J.
- Affiliations
- University of Chicago (US)
- The Kovler Diabetes Center (B.E.G., P.C.M., D.D., B.A.H., C.J.R.), Chicago, Illinois 60637
- University of Florida Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-09-01
- Volume
- 97
- Issue
- 9
- Pages
- 3197-3206
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3431572
- OpenAlex
- W2143050701
- Cited by
- 344
- References
- 50
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 20 · 2023: 23 · 2022: 26 · 2021: 31 · 2020: 26 · 2019: 25 · 2018: 26 · 2017: 23 · 2016: 26 · 2015: 33 · 2014: 21 · 2013: 18 · 2012: 1
- FWCI
- 23.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago
- National Institutes of Health (UL1TR000064)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 20595, DK-55267, R01DK055267, P60DK020595, P30DK020595)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell mass, beta-cell neogenesis, pancreatic islets, beta-cell proliferation, alpha cells, delta cells, somatostatin, glucagon, insulin, ductal cells, human lifespan, diabetes compensation, insulin resistance
- MeSH terms
- Adolescent, Adult, Aged, Autopsy, Cell Count, Child, Child, Preschool, Fluorescent Antibody Technique, Humans, Infant, Infant, Newborn, Infant, Premature, Islets of Langerhans, Middle Aged, Neurons, Pancreatic Hormones, Biomarkers, Paraffin Embedding, Pancreas, Exocrine, Cell Proliferation, Insulin-Secreting Cells, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.